Drug Device Combination Products
药物装置组合产品FDA指南
Combination product as indicated by the Code of Federal Regulation ,CFR is expressed as a product that includes a medical device /or a medication/or a biologic consolidating any two of these classifications and at some point even every one of the three. The well-known term of combination product is the drug eluting stent (DES) which is a scaffold covered with a drug to prevent scar tissue from developing in the supply artery. Most of the individuals have a constrained perspective on combination products. Today combination product are under development which includes a lot a larger number of things than just drugs, device or biological product , medical device. They include foods, they include nutraceuticals, and cosmetics agents or supposed as cosmeceuticals. Products that combine drug with device are named as Drug device combination.
根据FDA组合产品，组合产品的类型可以是单个实体，交叉标记，共包装。
组合产品表演样本，例如预填充的注射器，热带产品的涂抹器。制造商应进行充分的设计和开发活动，以证明产品的安全性和功效的充分性。这medical device design and developmentactivity is the systematic methodology, which establishes the proper design and development of the products. Many of the customer complaints and 483’s in case of the medical devices or combination devices are contributed to the improper of the design and development control activity. The design and development requirements of the product are described in ISO 13485：2016和21 CFR第820部分。按照美国FDA 21 CFR,Separate product packaged together in single package and comprise as biological and drug product ,device and biological product or drug and device product is termed as Co-packaged combination product. In a brief As per FDA, combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological product
组合产品项目开发过程和设计控制
制造商组合产品的制药组织预计将为组合产品的制造地点实施21 CFR部分210和211和21 CFR第820部分。在设计阶段的末尾，编译了DHF，并应在审核期间介绍。DMR应从DHF中提取，以进行常规使用和技术转移。DMR中提到的要求应用于创建DHR，以证明常规生产和合规性。根据ISO 13485：2016的要求，应建立医疗设备文件。设计过程的复杂性取决于产品的复杂性和预期用途。就质量管理系统而言，设计控制是至关重要的部分。
根据MDR进行CE标记的药物设备组合（DDC）188bet金搏宝滚球
Integral DDCs are products falling under the second sub-paragraphs of both Article 1(8) and Article 1(9) 62 of the Regulation (EU) 2017/745 on medical devices (the MDR).
Generally, These Devices Have Measuring, Metering or Delivery Functions.
积分DDC中医疗设备的示例是：
- 用于交付行动现场的设备，例如用眼睛的容器顶部的滴管将烟嘴放在喷雾罐的顶部以进行喉咙喷雾。
- 单剂量预注射器，笔和喷油器。
- 多剂量笔和喷油器，其中包含预填充的墨盒，无法更换墨盒，并且笔不得为随后与新墨盒一起使用。
- 释放药物的内部装置；阴道片剂预组装的，不可避免的涂药器。
- Dry powder inhalers that are assembled with the medicinal component and ready for use with single or multiple doses but cannot be refilled when all doses are taken.
- Implants containing medicinal products whose primary purpose is to release the medicinal product.
积分DDC中医疗设备的示例是：
- Oral administration devices (e.g. cups, spoons, syringes)
- Injection needles and filter needles
- Refillable pens and injectors (e.g. using cartridges).
- 可重复使用的干粉吸入器；吸入喷雾剂的垫片
- Pumps for medicinal product delivery
- Electronic tablet dispensers
Each Manufacturer of a Medical Device Shall Establish and Maintain Following Procedures
- 控制设备的设计
- 确保满足指定的设计要求
组合产品的CAPA管理
CAPA managementof drugs and device combination products are as follow:
To ensure that devices meet a requirement of Combination Products
- Users’ needs and intended uses
- Requirements and Specifications
- 这regulatory pathway for combination products
- Can be reproducibly and reliably manufactured, serviced and/or installed.
组合产品归档目的的工具
- 建立设计控制专业cedures.
- 制定设计项目的计划（包括研发与其他单位之间的接口）
- 确定该设备的设计输入要求和高级规格
- 开发设计输出（最终规格）
- Design Verification through measurement, analysis, test or inspection that all design outputs fulfil input requirements.
- Transfer outputs to production
- 设备按预期执行和功能的设计验证以及用户需要专家。
- 控制设计和开发过程中的更改以及现有设备记录设计历史记录文件中的设计活动。
188金宝搏网站靠谱吗操纵策略师作为可靠的医疗设备顾问assists companies and medical device manufacturers by providing consulting services that support the registration of drug-device Combination Products. We have experience with each constituent part and the GMP regulations that together form the basis for their development and manufacture: Drug (21 CFR 210/211), Device (21 CFR 820) and 21 CFR Combination Products (21 CFR Part 4)